Triveni Bio
Advancing new antibody treatments for immunological and inflammatory disorders.
Biotechnology
📍 Watertown, MA
Current Valuation
Private
PRIVATE
Advancing new antibody treatments for immunological and inflammatory disorders. Headquartered in Watertown, MA. Raised $65M in Series C funding in June 2026 led by Ascenta Capital.
Company Profile
Last Round
Series C — $65M (Jun 2026) · Lead: Ascenta Capital
Fundraising Status
Series C · $65M · this month
privateTotal raised $65M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $65M | Jun 2026 | Ascenta Capital | — |
Investors
Ascenta Capital · Janus Henderson Investors · Deep Track Capital
BiotechnologyPharmaceuticalsRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.